Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2026 16:05 ET | Source: HF Foods Group Inc.

HF Foods to Participate in the 38th Annual Roth Conference

LAS VEGAS, March 17, 2026 (GLOBE NEWSWIRE) -- HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a leading distributor of international foodservice solutions to Asian restaurants and...
March 17, 2026 16:05 ET | Source: Trevi Therapeutics, Inc.

Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates

Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with idiopathic pulmonary fibrosis-related chronic cough On...
March 17, 2026 16:05 ET | Source: Euroseas

Euroseas Ltd. Announces Order for the Construction of Two 2,800 TEU, High-Reefer Containerships

ATHENS, Greece, March 17, 2026 (GLOBE NEWSWIRE) -- Euroseas Ltd. (NASDAQ: ESEA, the “Company” or “Euroseas”), an owner and operator of container carrier vessels and provider of seaborne...
March 17, 2026 16:05 ET | Source: Longeveron

Longeveron Announces 2025 Full Year Financial Results and Provides Business Update

Longeveron reported financial results for the year ended December 31, 2025 and provided a business update. Results from pivotal P2 trial anticipated 3Q26.
March 17, 2026 16:05 ET | Source: Cibus US LLC

Cibus Reports Fourth Quarter Financial Results and Provides Business Update

SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today...
March 17, 2026 16:01 ET | Source: Royalty Pharma plc

Royalty Pharma Announces Expansion of Leadership Team

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced an expansion of its leadership team. Greg Butz will join Royalty Pharma as Executive Vice President,...
March 17, 2026 16:01 ET | Source: Kestra Medical Technologies, Ltd.

Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results

KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial...
March 17, 2026 16:01 ET | Source: SAB Biotherapeutics, Inc.

SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

MIAMI, March 17, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type...
March 17, 2026 16:01 ET | Source: IZEA Worldwide, Inc.

IZEA Achieves Record $18.9M Profitability Swing, Breaking Even on $31.2M of Revenue

Enterprise-first strategy and optimized cost structure results in profit turnaround with $50.9M in cash to fuel M&A and technology innovation ORLANDO, Fla., March 17, 2026 (GLOBE NEWSWIRE) --...
March 17, 2026 16:01 ET | Source: Lantheus Holdings, Inc.

Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

BEDFORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians...